Search

everythinglearnresearchcommunity

for

Search:↓

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Hair loss treatments work better with lifestyle changes.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Spironolactone plus finasteride reduces hirsutism more effectively.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Non-compliance with PCOS medication worsens symptoms and highlights the need for better patient support and education.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.